Loading...
XHKG
2158
Market cap424mUSD
Oct 09, Last price  
3.16HKD
1D
-3.36%
1Q
-40.93%
IPO
-95.06%
Name

Yidu Tech Inc

Chart & performance

D1W1MN
XHKG:2158 chart
P/E
39.18
P/S
3.48
EPS
0.07
Div yield, %
—
Shrs. gr., 5y
3.17%
Rev. gr., 5y
-1.83%
Revenues
791m
+10.56%
22,727,000102,013,000558,083,000867,036,0001,237,200,000804,700,000807,076,000714,979,000790,514,077
Net income
70m
P
-978,368,000-933,588,000-1,509,878,000-3,700,287,000-762,318,000-627,966,000-194,944,000-117,788,00070,154,556
CFO
-22m
L-91.16%
-167,725,000-372,726,000-360,554,000-331,678,000-614,676,000-357,013,000-326,383,000-248,814,000-21,998,000
Dividend
Sep 01, 20260.04 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Yidu Tech Inc. is a technology company that develops and deploys healthcare solutions leveraging big data and artificial intelligence. Its operations extend across Mainland China, Brunei, and other global regions. The company's business activities are categorized into four core segments: Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and a segment for Other ventures. The Big Data Platform and Solutions division provides sophisticated data intelligence platforms and analytics-driven solutions. These offerings cater to hospitals, diverse healthcare institutions, regulatory bodies, and policymakers, aiming to enhance research, clinical diagnosis and treatment, and operational efficiency. This segment specifically includes the provision of DPAP/Eywa platforms for medical organizations. Through its Life Sciences Solutions segment, the company delivers analytical services that support clinical development, real-world evidence (RWE) research, and digital commercialization strategies for pharmaceutical companies, biotechnology firms, and medical device manufacturers. The Health Management Platform and Solutions segment offers health management applications and services, as well as insurance technology (InsurTech) solutions for insurance companies, agencies, and relevant regulators. This segment also includes the distribution of insurance products and the sale of pharmaceuticals and associated hardware. The Others segment encompasses the sale of computer hardware, medical devices, insurance brokerage services, and engagement in medical and computer technology development. Yidu Tech Inc. was established in 2014 and is headquartered in Beijing, China.

Related entities

Subsidiaries (2)
Yidu AI Limited
Remarkable Panda Inc.

Key people

Yingying Gong
Executive Chairwoman of the Board · since 2023
Zhi He
Co-Founder and Chief Innovation Officer · since 2015
Xiaoying Feng
Chief Financial Officer, Executive Director, Joint Company Secretary · since 2023
Shi Zhang
Senior Vice President (Big Data Platform and Solutions) and Head of Government Affairs, Executive Director · since 2020
Jun Yan
Chief Technology Officer · since 2025
Li Xie
Executive Director · since 2025
Jiming Xu
Chief Executive Officer, Senior Vice President - Life Sciences Solutions, Executive Director · since 2023
Joint Company Secretary · since 2020
Non-Executive Director · since 2021
Wei-Ying Ma
Independent Non-Executive Director · since 2021
Rongrong Pan
Independent Non-Executive Director · since 2021
Linqi Zhang
Independent Non-Executive Director · since 2021
IPO date
Jan 15, 2021
Employees
1,020
Domiciled in
CN
Incorporated in
KY
Headquarters & legal address
Suite #4-210, Governors Square,
23 Lime Tree Bay Avenue
PO Box 32311
Grand Cayman KY1-1209
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT